e-learning
resources
Virtual 2021
06.09.2021
Therapy of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.
L. Saunders (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom)
Source:
Virtual Congress 2021 – Therapy of pulmonary hypertension
Session:
Therapy of pulmonary hypertension
Session type:
E-poster
Number:
1934
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Saunders (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom). MRI metric lung parenchyma T1 indicates lung pathology in patients with pulmonary hypertension.. 1934
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
HRCT imaging of lung parenchyma in chronic heart failure (CHF) patients: correlation with pulmonary function tests
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008
Correlation of CT estimated lung volumes with pulmonary function tests in COPD patients
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
Lung cancer in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 17: 1216-1219
Year: 2001
Paradoxically normal lung volume assessed by CXR and total lung capacity in patients with diffuse pulmondary fibrosis and additional emphysema
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
A histopathological grading system for vascular remodelling in lung volume reduction surgery (LVRS)
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Changes in pulmonary
18
F-FDG SUVmax reflect treatment response in patients with diffuse parenchymal lung disease; a PET/CT proof of concept study
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Prediction of survival in interstitial lung disease (ILD); role of DTPA lung clearance scans and lung function variables
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020
Twelve lung zones protocol of ultrasound mapping in idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Thoracic ultrasound in clinical practice
Year: 2019
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Histology of arteriolar wall remodelling in a lung volume reduction surgery (LVRS) patient cohort
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
3he MRI and an animal model of interstitial lung disease
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015
CT and interstitial lung disease
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
The correlation between pathological findings of transbronchial lung cryobiopsy and high resolution CT morphology for diffuse parenchymal lung disease patients
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
Voxelwise lung pattern transition scores on HRCT images and their association with symptoms in patients with idiopathic pulmonary fibrosis
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept